Ozempic Lizard Venom? What Exendin-4 Really Teaches About GLP-1 Peptide Science
The viral Ozempic lizard venom story points to real peptide science. Learn how exendin-4, exenatide, and semaglutide fit together.
June 14, 20268 min read
Read Article ›The Peptide Chronicle
Science, Policy & Truth
Objective, peer-reviewed reporting on therapeutic peptides, regulatory updates, clinical trial results, and scientific consensus. No hype. No product sales.
Tag: Peptide Safety
Recent Posts
Articles tagged Peptide Safety.
Retatrutide Is Trending: What Google Searches and GLP-1 Hype Miss About Peptide Safety
Retatrutide search interest is rising alongside GLP-1 hype. Here is what the evidence says, what remains investigational, and why gray-market peptides are risky.
June 13, 20268 min read
Read Article ›Peptide Injections Are Trending: How to Separate GLP-1 Science From Wellness Hype
Peptide injections are suddenly everywhere in wellness culture. Here is how GLP-1 evidence differs from experimental stacks like BPC-157, MOTS-c, and TB-500.
June 12, 20269 min read
Read Article ›Peptides Are Trending Everywhere: GLP-1s, Retatrutide, BPC-157, and the Safety Question in 2026
Peptides are trending because GLP-1 drugs, retatrutide buzz, and research-use peptides have converged into one urgent health conversation.
June 10, 20269 min read
Read Article ›No articles match that search.